Pulished Date August, 2019
ID: 7672
Share on
Share on

Asia-Pacific Platelet Rich Plasma Market Research Report - Segmented By Application, By Product, By Origin & By Country(India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC) - Industry Analysis, Size, Share, Growth, Trends And Forecasts (2019-2024)

Pulished: August, 2019
ID: 7672
Pages: 145

APAC Platelet Rich Plasma Market Size & Growth (2019 – 2024)

As per the research report, the Asia-Pacific Platelet Rich Plasma market size was around USD 62.59 million in 2019. It is expected to grow at a CAGR of 15.92% to reach USD 131.01 million by 2024 during the forecast period 2019-2024.

Platelet-rich Plasma is purified plasma protein with red blood cells removed out of it and used for its greater concentration of growth factors. Platelet-rich plasma can regenerate ligaments and tendon fibres. PRP treatments are tissue healing techniques with a wide range of applications. Rise in Cosmetic surgeries and orthopaedic diseases are the key growth factors of this market. In some cases, PRP therapy can prevent the need for surgery which is helping the market grow rapidly. The lack of any possible side effects of this process is making the demand for PRP much higher.

This research report segmented and sub-segmented into the following categories:

  • By Application: Orthopaedics, Cosmetic Surgery, Ophthalmic Surgery, Neurosurgery
  • By Product: Pure, Leukocyte-Rich, Leukocyte-Rich Fibrin
  • By Origin: Homologous PRP, Autologous PRP, Allogeneic PRP    
  • By Country: India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC

The market is dominated by pure PRP segment because of less inflammatory responses and effective results in bone regeneration. Leukocyte-rich PRP is expected to rise with a high growth rate owing to its efficiency in healing soft tissue. PRP therapy is the go-to method for soft tissue healing and thus is projected to grow steadily in market value in upcoming years.

With growing awareness towards PRP therapy, there is huge potential for Platelet Rich Plasma market to thrive in Asia-Pacific region over the next decade.

The Top companies leading in the APAC Platelet Rich Plasma Market profiled in the report are DR. PRP AMERICA, LLC, Glofinn Oy, Zimmer Biomet, DePuy Synthes, Emcyte Corporation,Terumo BCT, Anthrex Inc, T-Biotechnology, Stryker.

1. Introduction        

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods 

                1.4 General Study Assumptions                

2. Research Methodology                  

                2.1 Introduction      

                2.2 Research Phases                      

       2.2.1 Secondary Research           

       2.2.2 Primary Research 

       2.2.3 Econometric Modelling      

       2.2.4 Expert Validation  

                2.3 Analysis Design

                2.4 Study Timeline 

3. Overview              

                3.1 Executive Summary                

                3.2 Key Inferences

                3.3 Epidemology     

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)           

                4.1 Market Drivers 

                4.2 Market Restraints                    

                4.3 Key Challenges

                4.4 Current Opportunities in the Market     

5. Market Segmentation                     

                5.1 Application                 

       5.1.1 Introduction           

       5.1.2 Orthopedics           

       5.1.3 Cosmetic Surgery 

       5.1.4 Ophthalmic surgery             

       5.1.5 Neurosurgery        

       5.1.6  Y-o-Y Growth Analysis, By Application        

       5.1.7  Market Attractiveness Analysis, By Application      

       5.1.8  Market Share Analysis, By Application       

                5.2 Product                        

       5.2.1 Introduction           

       5.2.2 Pure           

       5.2.3 Leukocyte-Rich     

       5.2.4 Leukocyte-Rich Fibrin         

       5.2.5 Y-o-Y Growth Analysis, By Type     

       5.2.6 Market Attractiveness Analysis, By Type   

       5.2.7 Market Share Analysis, By Type     

                5.3 Origin   

       5.3.1 Introduction           

       5.3.2 Homologous PRP  

       5.3.3 Autologous PRP    

       5.3.4 Allogeneic PRP      

       5.3.5 Y-o-Y Growth Analysis, By Origin   

       5.3.6 Market Attractiveness Analysis, By Origin 

       5.3.7 Market Share Analysis, By Origin   

6. Geographical Analysis                     

                6.1 Introduction      

       6.1.1 Regional Trends    

       6.1.2 Impact Analysis     

       6.1.3 Y-o-Y Growth Analysis        

                       6.1.3.1 By Geographical Area

                       6.1.3.2 By Application

                       6.1.3.3 By Product

                       6.1.3.4 By Origin

       6.1.4  Market Attractiveness Analysis     

                       6.1.4.1 By Geographical Area

                       6.1.4.2 By Application

                       6.1.4.3 By Product

                       6.1.4.4 By Origin

       6.1.5  Market Share Analysis      

                       6.1.5.1 By Geographical Area

                       6.1.5.2 By Application

                       6.1.5.3 By Product

                       6.1.5.4 By Origin

                6.2 China    

                6.3 India     

                6.4 Japan   

                6.5 South Korea      

                6.6 Australia                      

7. Strategic Analysis              

                7.1 PESTLE analysis

       7.1.1 Political     

       7.1.2 Economic 

       7.1.3 Social         

       7.1.4 Technological         

       7.1.5 Legal          

       7.1.6 Environmental       

                7.2 Porter’s Five analysis     

       7.2.1 Bargaining Power of Suppliers        

       7.2.2 Bargaining Power of Consumers    

       7.2.3 Threat of New Entrants     

       7.2.4 Threat of Substitute Products and Services              

       7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis               

                8.1 Zimmer Biomet

       8.1.1 Overview 

       8.1.2 Product Analysis   

       8.1.3 Financial analysis  

       8.1.4 Recent Developments       

       8.1.5 SWOT analysis       

       8.1.6 Analyst View          

                8.2 DR. PRP AMERICA                    

                8.3 LLC                 

                8.4 Gloffin Oy                   

                8.5 Depuy Synthes

                8.6 Emcyte Cororation                  

                8.7 Terumbo BCT    

                8.8 Anthrex Inc                

                8.9 T-Biotechnology                       

                8.10 Stryker                       

9. Competitive Landscape                  

                9.1 Market share analysis   

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures

                9.4 New Product Launches

10. Market Outlook and Investment Opportunities                

Appendix                  

                a) List of Tables                

                b) List of Figures     

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms By Product Others with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Asia Pacific Platelet Rich Plasma Market By Product, From 2019-2024 ( USD Million )
  2. Asia Pacific Pure Market By Region, From 2019-2024 ( USD Million )
  3. Asia Pacific Leukocyte Rich Market By Region, From 2019-2024 ( USD Million )
  4. Asia Pacific Leukocyte rich Fibrin Market By Region, From 2019-2024 ( USD Million )
  5. Asia Pacific Platelet Rich Plasma Market By Application, From 2019-2024 ( USD Million )
  6. Asia Pacific Orthopedics Market By Region, From 2019-2024 ( USD Million )
  7. Asia Pacific Ophthalmic surgery Market By Region, From 2019-2024 ( USD Million )
  8. Asia Pacific Cosmetic surgery Market By Region, From 2019-2024 ( USD Million )
  9. Asia Pacific Neurosurgery Market By Region, From 2019-2024 ( USD Million )
  10. Japan Platelet Rich Plasma Market By Product, From 2019-2024 ( USD Million )
  11. Japan Platelet Rich Plasma Market By Application, From 2019-2024 ( USD Million )
  12. China Platelet Rich Plasma Market By Product, From 2019-2024 ( USD Million )
  13. China Platelet Rich Plasma Market By Application, From 2019-2024 ( USD Million )
  14. India Platelet Rich Plasma Market By Product, From 2019-2024 ( USD Million )
  15. India Platelet Rich Plasma Market By Application, From 2019-2024 ( USD Million )
  16. Australia Platelet Rich Plasma Market By Product, From 2019-2024 ( USD Million )
  17. Australia Platelet Rich Plasma Market By Application, From 2019-2024 ( USD Million )
  18. South Korea Platelet Rich Plasma Market By Product, From 2019-2024 ( USD Million )
  19. South Korea Platelet Rich Plasma Market By Application, From 2019-2024 ( USD Million )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample